Found: 9
Select item for more details and to access through your institution.
Rad10 exhibits lesion-dependent genetic requirements for recruitment to DNA double-strand breaks in Saccharomyces cerevisiae.
- Published in:
- Nucleic Acids Research, 2009, v. 37, n. 19, p. 6429, doi. 10.1093/nar/gkp709
- By:
- Publication type:
- Article
Intrinsically de-sialylated CD103 CD8 T cells mediate beneficial anti-glioma immune responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 911, doi. 10.1007/s00262-014-1559-2
- By:
- Publication type:
- Article
Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 24, p. 7259, doi. 10.3390/jcm11247259
- By:
- Publication type:
- Article
Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00665-z
- By:
- Publication type:
- Article
Chimeric Antigen Receptors With Mutated IgG4 Fc Spacer Avoid Fc Receptor Binding and Improve T Cell Persistence and Antitumor Efficacy.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 4, p. 757, doi. 10.1038/mt.2014.208
- By:
- Publication type:
- Article
KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL): Outcomes in Patients Who Were Treated with Prior Blinatumomab in ZUMA-3.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S184, doi. 10.1016/j.clml.2018.07.015
- By:
- Publication type:
- Article
KTE-C19 (anti-CD19 chimeric antigen receptor [CAR] T cell therapy) in pediatric and adolescent patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL): Preliminary Results of ZUMA-4.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S252, doi. 10.1016/j.clml.2017.07.013
- By:
- Publication type:
- Article
Axi-cel, an Anti-CD19 Chimeric Antigen Receptor (CAR) T cell Therapy in Adult Patients (Pts) With Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) in the ZUMA-3 Trial: Preliminary Results of Novel Safety Interventions.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S253, doi. 10.1016/j.clml.2017.07.014
- By:
- Publication type:
- Article
TGF-β Induces Acetylation of Chromatin and of Ets-1 to Alleviate Repression of miR-192 in Diabetic Nephropathy.
- Published in:
- Science Signaling, 2013, v. 6, n. 278, p. 1, doi. 10.1126/scisignal.2003389
- By:
- Publication type:
- Article